JANX

Janux Therapeutics (JANX)

About Janux Therapeutics (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$14.72

Daily low

$14.16

Price at open

$14.37

52 Week High

$35.34

52 Week Low

$12.12

Market cap

867.2M

Dividend yield

0.00%

Volume

911,752

Avg. volume

849,313

P/E ratio

-7.72

Janux Therapeutics News